When Kay Wesley moved from the world of dot com to work as global digital director at AstraZeneca, she realised that pharma was transforming for digital at a rather different pace.
If a particularly important and digitally well-connected HCP tweeted about your new data today, and assuming 50% of their HCP followers retweeted that, and assuming 50% of those followers’
A large number of US consumers are wary of content from social media, presenting opportunities for pharma to become trusted resources for health information, says Richard Meyer.
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho